[{"Assets_0_FY_USD":512071000.0,"CommonStockSharesConverted_0_FY_shares":107648925.0,"CommonStockSharesOutstanding_0_FY_shares":107648925.0,"EarningsPerShareBasic_4_FY_USD":-5.76,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-129632000.0,"NetIncomeLossConverted_1_FY_USD":-63771000.0,"NetIncomeLossConverted_4_FY_USD":-174683000.0,"RevenuesConverted_4_FY_USD":8091000.0,"RevenuesConverted_1_FY_USD":980000.0,"StockholdersEquity_0_FY_USD":423942000.0,"EarningsPerShareBasic_1_FY_USD":-0.69,"EarningsPerShareDiluted_1_FY_USD":-0.71,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200326"}]